2.9(top 20%)
impact factor
1.1K(top 20%)
papers
18.9K(top 10%)
citations
54(top 10%)
h-index
3.1(top 20%)
impact factor
1.3K
all documents
20.4K
doc citations
79(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre studyEJNMMI Research2015250
2Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from 18F-FDG PET/CT imagesEJNMMI Research2017194
3Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjectsEJNMMI Research2011149
4PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjectsEJNMMI Research2018144
544Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617EJNMMI Research2017140
6Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CTEJNMMI Research2013137
7Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancerEJNMMI Research2014137
8A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerEJNMMI Research2012134
9Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheresEJNMMI Research2013129
10IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantomsEJNMMI Research2017125
11Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfareEJNMMI Research2012124
12Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCISTEJNMMI Research2019121
13Emerging role of radiolabeled nanoparticles as an effective diagnostic techniqueEJNMMI Research2012120
14Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosisEJNMMI Research2014118
15Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapyEJNMMI Research2015118
16A dual tracer 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT pilot study for detection of cardiac sarcoidosisEJNMMI Research2016112
1768Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factorsEJNMMI Research2012107
18Novel 89Zr cell labeling approach for PET-based cell trafficking studiesEJNMMI Research2015107
19Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumourEJNMMI Research2016104
20Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PETEJNMMI Research2012100
2118F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)EJNMMI Research201199
22Radiofluorination using aluminum-fluoride (Al18F)EJNMMI Research201398
23The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDGEJNMMI Research201396
24Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CTEJNMMI Research201392
25The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic reviewEJNMMI Research201591
26[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgeryEJNMMI Research201588
27Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjectsEJNMMI Research201286
28Performance evaluation of the next generation solid-state digital photon counting PET/CT systemEJNMMI Research201883
2964Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patientsEJNMMI Research201582
30Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reportingEJNMMI Research201381
31Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176—based on recent publications that measured specific-to-non-displaceable ratiosEJNMMI Research201780
32For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition timeEJNMMI Research201679
33Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targetsEJNMMI Research201178
34PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsyEJNMMI Research201278
35Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomyEJNMMI Research201678
36Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?EJNMMI Research201776
37Nuclear imaging of inflammation: homing-associated molecules as targetsEJNMMI Research201375
38Nanobody: a promising toolkit for molecular imaging and disease therapyEJNMMI Research202175
39Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activationEJNMMI Research201173
40Optimized dose regimen for whole-body FDG-PET imagingEJNMMI Research201373
41Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer modelsEJNMMI Research201671
42Assessment of acquisition protocols for routine imaging of Y-90 using PET/CTEJNMMI Research201367
43In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106EJNMMI Research201366
44Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CTEJNMMI Research201764
45Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumorsEJNMMI Research201563
46Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancerEJNMMI Research201560
47Longitudinal analysis of bone metabolism using SPECT/CT and 99mTc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysisEJNMMI Research201660
48Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scannerEJNMMI Research201258
49Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft modelsEJNMMI Research201758
50Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancerEJNMMI Research201858